ITCI

Intra-Cellular Therapies Inc.

Delisted

ITCI was delisted on the 1st of April, 2025.

383 hedge funds and large institutions have $8.08B invested in Intra-Cellular Therapies Inc. in 2024 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 132 increasing their positions, 136 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
383
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
15
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$25.4M
Puts
$11M
Net Calls
Net Calls Change

Top Buyers

1 +$41.2M
2 +$33.6M
3 +$33.4M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$13.8M
5
O
OrbiMed
New York
+$13.6M
Name Holding Trade Value Shares
Change
Change in
Stake
276
$286K
277
$284K
278
$283K
279
$283K
280
$279K
281
$277K
282
$273K
283
$267K
284
$266K
285
$256K
286
$254K
287
$253K
288
$251K
289
$251K
290
$250K
291
$247K
292
$247K
293
$247K
294
$237K
295
$234K
296
$225K
297
$224K
298
$219K
299
$214K
300
$212K